0000899243-19-004676.txt : 20190225 0000899243-19-004676.hdr.sgml : 20190225 20190225154030 ACCESSION NUMBER: 0000899243-19-004676 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190221 FILED AS OF DATE: 20190225 DATE AS OF CHANGE: 20190225 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gibbs Michael Terrence CENTRAL INDEX KEY: 0001665000 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36571 FILM NUMBER: 19629269 MAIL ADDRESS: STREET 1: 12 STONEY BROOK RD. CITY: HOPKINTON STATE: MA ZIP: 01748 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: T2 Biosystems, Inc. CENTRAL INDEX KEY: 0001492674 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204827488 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-457-1200 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-21 0 0001492674 T2 Biosystems, Inc. TTOO 0001665000 Gibbs Michael Terrence 101 HARTWELL AVENUE LEXINGTON MA 02421 0 1 0 0 General Counsel Stock Option (Right to Buy) 3.72 2019-02-21 4 A 0 60000 0.00 A 2029-02-21 Common Stock 60000 60000 D Restricted Stock Units 2019-02-21 4 A 0 30000 0.00 A Common Stock 30000 30000 D The stock option vests in 48 equal monthly installments commencing February 21, 2019. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in three equal annual installments commencing February 21, 2020. /s/ John Sprague, Attorney-in-fact 2019-02-25